tiprankstipranks
Trending News
More News >
Curaleaf Holdings (OTC) (TSE:CURA)
OTHER OTC:CURA
Canadian Market

Curaleaf Holdings (CURA) Earnings Dates, Call Summary & Reports

Compare
388 Followers

Earnings Data

Report Date
May 07, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.1
Last Year’s EPS
-0.1
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 26, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
The call presents a mixed but constructive picture: strong operational momentum (cultivation yield gains, record potency, brand share gains, international revenue surge, positive cash flow and a landmark refinancing) contrasts with persistent industry-wide price compression, declining adjusted EBITDA and significant net losses. Management articulated a clear turnaround playbook and expects industry dynamics (hemp ban and rescheduling) to improve pricing and drive consolidation, but near-term profitability headwinds and elevated SG&A and debt costs keep financial risk tangible. Overall, operational progress is meaningful and de-risking steps (refinancing, cost discipline, product quality gains) are clear, yet material losses and margin compression temper the near-term outlook.
Company Guidance
Curaleaf’s explicit guidance was limited but measurable: for Q1 management expects total revenue to be down mid‑single digits sequentially from Q4 revenue of $333 million; 2026 capital expenditures are guided at approximately $80 million (with spending focused on international, automation, store relocations/renovations, IT and HQ relocation) and the company plans at least 10 new dispensary openings; international gross margins are expected to remain roughly flat in 2026 in the low‑to‑mid 40% range (~42–43%) with further improvement toward a ~50% adjusted gross margin as scale is achieved in 2027; management also expects the federal hemp ban (scheduled to take effect in November) to help stabilize pricing later in the year and to drive migration of roughly 50% of the ~$25 billion hemp market back to the regulated channel; lastly, Curaleaf completed a refinancing replacing $475 million of notes (≈$457 million outstanding) with a $500 million senior secured note due Feb 18, 2029 at an 11.5% coupon, while ending the quarter with $102 million of cash and $549 million of total debt.
Fourth Quarter Revenue Growth
Q4 revenue of $333 million, up 5% sequentially and 2% year-over-year, marking the company's strongest quarterly performance in six quarters.
Full-Year Revenue and Margins
Full-year 2025 revenue of $1.27 billion with adjusted gross margin of 50% and adjusted EBITDA of $275 million (22% of revenue).
International Revenue Surge
Curaleaf International Q4 revenue of $51 million (10% sequential growth and 65% year-over-year) and full-year international revenue of $172 million, up ~63% versus 2024; international business on a >$200 million annual run rate.
Margin Expansion Driven by Cultivation Productivity
Adjusted gross margin expanded to 49% in Q4 (up 20 basis points YoY) and to 50% for the full year (up 150 basis points YoY), driven by doubled yields, productivity gains in cultivation and higher average flower potency (31%, a company record).
Strong Cash Generation and Liquidity Management
Q4 operating cash flow from continuing operations of $42 million and free cash flow of $25 million. Full-year operating cash flow of $152 million and free cash flow of $89 million; cash balance of $102 million at year-end.
Brand and Product Momentum
Anthem pre-roll launches became a top 5 national pre-roll brand in four launch markets; Select maintained #1 vape share and Curaleaf captured #1 overall market share per Hoodie Analytics; launch of Briq 2.0 vape platform and Dark Heart premium expansion planned.
Wholesale Growth and Retail Expansion
Wholesale revenue increased 15% year-over-year to $91 million, representing 27% of total revenue. Company opened 9 new dispensaries in 2025 (5 Florida, 3 Ohio, 1 Maine).
Debt Refinancing and Strategic Financial Moves
Completed refinancing of prior senior secured notes with a new $500 million senior secured note (11.5% coupon) maturing Feb 18, 2029, extending maturities, reducing short-term refinancing risk, and demonstrating strong investor demand. Acquisition debt reduced by $57 million during the year.

Curaleaf Holdings (TSE:CURA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:CURA Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 2026
2026 (Q1)
-0.10 / -
-0.096
Feb 26, 2026
2025 (Q4)
-0.10 / -0.08
-0.13740.00% (+0.05)
Nov 05, 2025
2025 (Q3)
-0.10 / -0.09
-0.0965.71% (<+0.01)
Aug 06, 2025
2025 (Q2)
-0.09 / -0.08
-0.0820.00% (0.00)
May 08, 2025
2025 (Q1)
-0.09 / -0.10
-0.0960.00% (0.00)
Mar 03, 2025
2024 (Q4)
-0.09 / -0.14
-0.109-25.00% (-0.03)
Nov 06, 2024
2024 (Q3)
-0.08 / -0.10
-0.12322.22% (+0.03)
Aug 07, 2024
2024 (Q2)
-0.08 / -0.08
-0.12333.33% (+0.04)
May 09, 2024
2024 (Q1)
-0.08 / -0.10
-0.068-40.00% (-0.03)
Mar 06, 2024
2023 (Q4)
-0.07 / -0.11
-0.49277.78% (+0.38)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

TSE:CURA Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2026
C$3.33C$3.19-4.20%
Nov 05, 2025
C$4.01C$3.44-14.21%
Aug 06, 2025
C$2.31C$2.41+4.33%
May 08, 2025
C$1.21C$1.14-5.79%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Curaleaf Holdings (OTC) (TSE:CURA) report earnings?
Curaleaf Holdings (OTC) (TSE:CURA) is schdueled to report earning on May 07, 2026, After Close (Confirmed).
    What is Curaleaf Holdings (OTC) (TSE:CURA) earnings time?
    Curaleaf Holdings (OTC) (TSE:CURA) earnings time is at May 07, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:CURA EPS forecast?
          TSE:CURA EPS forecast for the fiscal quarter 2026 (Q1) is -0.1.

            Curaleaf Holdings (TSE:CURA) Earnings News

            Curaleaf (TSE:CURA) Misses Q3-2022 Earnings Estimates, but There’s Potential Here
            Premium
            Market News
            Curaleaf (TSE:CURA) Misses Q3-2022 Earnings Estimates, but There’s Potential Here
            3y ago